Q2 Earnings Estimate for LXRX Issued By Leerink Partnrs
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Lexicon Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 13th. Leerink Partnrs analyst R. Ruiz anticipates that the biopharmaceutical company will earn ($0.09) per share for […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Lexicon Pharmaceuticals in a research report issued to clients and investors on Tuesday, May 13th. Leerink Partnrs analyst R. Ruiz anticipates that the biopharmaceutical company will earn ($0.09) per share for […]
